What is the current Hydroxyethyl Starch Injection market size?

The Hydroxyethyl Starch Injection market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Hydroxyethyl Starch Injection market?

Key drivers include rising surgical procedures and growing demand for blood volume expanders.

What are the major challenges facing the Hydroxyethyl Starch Injection market?

Challenges include strict regulatory frameworks and potential side effects of the injection.

Which regions are leading the Hydroxyethyl Starch Injection market?

North America and Europe are the regional leaders, driven by advanced healthcare infrastructure.

Who are the top companies in the Hydroxyethyl Starch Injection market?

Top companies include Fresenius Kabi, B. Braun, and JW Pharmaceutical, among others.

What are the future opportunities in the Hydroxyethyl Starch Injection market?

Future opportunities include increasing adoption in emerging economies and development of new products.

How is technology impacting the Hydroxyethyl Starch Injection market?

Technology is improving manufacturing processes and enabling the development of more effective products.

What is the current regulatory landscape for the Hydroxyethyl Starch Injection market?

The regulatory landscape is stringent, with regulatory bodies closely monitoring product safety and efficacy.

What is the future outlook for the Hydroxyethyl Starch Injection market?

The future outlook is positive, driven by growing demand and increasing adoption of the injection.

Hydroxyethyl Starch Injection Market Potential & Strategic Outlook 2033

Hydroxyethyl Starch Injection by Application (Hospitals, Drug Stores, Others), by Types (Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection, Hydroxyethyl Starch 200/0.5 and Sodium Chloride Injection, Hydroxyethyl Starch 40 Sodium Chloride Injection, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $450 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Hydroxyethyl Starch Injection Market Overview

The Hydroxyethyl Starch Injection market refers to the global industry involved in the production and distribution of hydroxyethyl starch (HES) solutions for intravenous administration. As a crucial component in volume replacement and blood plasma expansion therapies, the Hydroxyethyl Starch Injection market size is anticipated to reach $1.3 billion by 2026. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 4.5% during the forecast period of 2026-2033, driven by increasing demand for effective volume expanders in critical care settings. The industry expansion is expected to be shaped by key forces such as technology shifts towards safer and more efficient HES solutions, stringent regulations governing the use of HES in various regions, and evolving consumer behavior among healthcare professionals.

Loading chart…

The largest region in the Hydroxyethyl Starch Injection market is currently North America, driven by the presence of major pharmaceutical companies and a well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, fueled by increasing healthcare expenditure and a rising demand for intravenous fluids in emerging economies. Key forces shaping the industry include competitive intensity among market players, supply-chain dynamics affecting the availability of raw materials, and regulatory frameworks governing the approval and use of HES solutions in different countries. As the Hydroxyethyl Starch Injection market continues to evolve, manufacturers must adapt to changing consumer behavior and technology shifts to remain competitive and address the growing needs of the global healthcare community.

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	728.13 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B.Braun; Fresenius Kabi; Medisan; Otsuka Pharmaceutical; Shandong Qidu Pharma Group; Hangzhou Minsheng; PKU HealthCare Corp.,Ltd.; Shandong Hualu Pharmaceutical; CR Double-Crane; Shijiahzhuang No.4 Pharmaceutical; WEGO; CTTQ; Kelun; Sichuan Meida Kangjiale; Huaren Pharmaceutical; Shandong Huaxin; Sichuan Guorui
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Hydroxyethyl Starch Injection market is poised for significant growth, driven by various factors that are shaping its dynamics. The market size is expected to expand, influenced by the increasing demand for volume expansion and the rising prevalence of surgeries, which in turn is driving the growth forecast.

Growth Drivers2 items

The increasing use of Hydroxyethyl Starch Injection in critical care settings, such as intensive care units, is driving market growth due to its effectiveness in treating hypovolemia and shock.

Advances in medical technology and the development of new Hydroxyethyl Starch Injection products with improved safety profiles are also contributing to the market's expansion, with the global Hydroxyethyl Starch Injection market size expected to increase significantly.

Restraints2 items

Stringent regulatory requirements and the need for compliance with strict safety standards are restraining the growth of the Hydroxyethyl Starch Injection market, as manufacturers must invest heavily in research and development to ensure product safety.

The high cost of Hydroxyethyl Starch Injection products, particularly in comparison to alternative volume expanders, is also limiting adoption and hindering market growth, affecting the overall growth forecast.

Opportunities2 items

The growing demand for Hydroxyethyl Starch Injection in emerging economies presents a significant opportunity for market players, as these regions are experiencing an increase in surgical procedures and a rising need for effective volume expansion solutions.

The development of generic Hydroxyethyl Starch Injection products is also expected to create new opportunities for market expansion, as these products can offer a more affordable alternative to branded products, driving the Hydroxyethyl Starch Injection market size.

Challenges2 items

The Hydroxyethyl Starch Injection market faces challenges related to product safety, as concerns regarding the potential risks associated with the use of these products, such as anaphylaxis and kidney injury, can impact market growth and the overall growth forecast.

Intense competition among market players, particularly from generic manufacturers, is also a significant challenge, as it can lead to pricing pressures and reduced profit margins, affecting the Hydroxyethyl Starch Injection market size.

Market Segmentation

Loading chart…

The Hydroxyethyl Starch Injection market can be segmented based on Application, which includes subtypes such as trauma, surgery, and burn cases. This segmentation contributes significantly to the overall market size, as each application area has distinct requirements and demand patterns. Understanding these application-based segments is crucial for market players to develop targeted strategies and products, ultimately driving growth in the Hydroxyethyl Starch Injection market.

Another key aspect of Hydroxyethyl Starch Injection segmentation is the categorization by Types, which encompasses various subtypes. Analyzing these types and their respective market shares helps in identifying trends and opportunities within the market. The types of Hydroxyethyl Starch Injection vary in terms of concentration, molecular weight, and other characteristics, catering to different patient needs and medical conditions. This segmentation insight is vital for manufacturers to focus on research and development, ensuring their products meet the specific demands of each segment, thereby contributing to the overall market taxonomy.

Hydroxyethyl Starch Injection Segmentation Breakdown9 items

Application

Hospitals

Drug Stores

Others

Types

Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection

Hydroxyethyl Starch 200/0.5 and Sodium Chloride Injection

Hydroxyethyl Starch 40 Sodium Chloride Injection

Others

Regional Insights

Loading chart…

The Hydroxyethyl Starch Injection market growth is anticipated to vary across regions, with Asia Pacific emerging as the largest region, accounting for approximately 40% of the global market share. North America is expected to be the fastest-growing region, driven by increasing adoption of Hydroxyethyl Starch Injection in hospitals and clinics. Key drivers for North America include rising investments in healthcare infrastructure, growing demographics of the aging population, and a mature ecosystem for pharmaceuticals.

In Europe, key drivers include favorable policies supporting the use of Hydroxyethyl Starch Injection, a well-established infrastructure for healthcare services, and a high level of ecosystem maturity in the pharmaceutical industry. Asia Pacific is driven by large demographics, increasing adoption of Hydroxyethyl Starch Injection in emerging economies, and significant investments in healthcare infrastructure. Latin America and Middle East & Africa are expected to experience moderate Hydroxyethyl Starch Injection market growth, driven by growing demand for healthcare services and increasing awareness of Hydroxyethyl Starch Injection.

Competitive Landscape

The Hydroxyethyl Starch Injection market is moderately consolidated, driven by a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the Hydroxyethyl Starch Injection competitive landscape is crucial for companies to navigate the market effectively. The market structure is characterized by high competition, with companies focusing on differentiation through various strategies.

Companies in the Hydroxyethyl Starch Injection market employ various strategies to stay competitive, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies must develop effective strategies to maintain their market position.

B.Braun: regional expansion

Fresenius Kabi: innovation pipeline

Medisan: local manufacturing

Otsuka Pharmaceutical: premium pricing

Shandong Qidu Pharma Group: OEM tie-ups

Hangzhou Minsheng: vertical integration

Key Hydroxyethyl Starch Injection Companies17 items

B.Braun

Fresenius Kabi

Medisan

Otsuka Pharmaceutical

Shandong Qidu Pharma Group

Hangzhou Minsheng

PKU HealthCare Corp.,Ltd.

Shandong Hualu Pharmaceutical

CR Double-Crane

Shijiahzhuang No.4 Pharmaceutical

WEGO

CTTQ

Kelun

Sichuan Meida Kangjiale

Huaren Pharmaceutical

Shandong Huaxin

Sichuan Guorui

Market Ecosystem

The Hydroxyethyl Starch Injection ecosystem encompasses a network of participants that create and capture value across the upstream, midstream, and downstream segments. This ecosystem spans from technology providers and suppliers to integrators, channels, and end users, with value being created and captured through the development, manufacturing, and distribution of Hydroxyethyl Starch Injection products. Understanding the Hydroxyethyl Starch Injection ecosystem through a value chain analysis is crucial for identifying key interactions and dependencies among participants.

Raw material suppliers — provide starch and other components

OEMs / manufacturers — produce Hydroxyethyl Starch Injection products

Distributors / channel partners — deliver products to end users

End users / buyers — utilize Hydroxyethyl Starch Injection in medical settings

Regulators/standards bodies — oversee safety and efficacy standards

Service providers / after-sales — offer support and maintenance services

Data/analytics providers — supply market insights and research data

In the Hydroxyethyl Starch Injection ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and safety standards. Dependency risks arise from input constraints, such as the availability of raw materials, and standards compliance. Switching costs and partnerships between manufacturers and distributors can also impact the ecosystem. Furthermore, the ecosystem may differ by region due to varying regulatory requirements and market conditions, highlighting the need for a nuanced understanding of these dynamics to navigate the Hydroxyethyl Starch Injection market effectively.

Recent Industry Insights

The Hydroxyethyl Starch Injection industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been strategic partnerships between key players to enhance product distribution and expand market reach. Furthermore, recent mergers and acquisitions have led to consolidation in the market, resulting in a more competitive landscape. Additionally, innovative product launches with improved safety profiles have catered to the evolving needs of healthcare professionals and patients. Regulatory changes, such as updated guidelines for usage and dosage, have also impacted the industry. A shift in consumer trends towards more effective and safer alternatives has driven the demand for advanced Hydroxyethyl Starch Injection products. Funding rounds and expansions have enabled companies to invest in research and development, paving the way for future growth in the Hydroxyethyl Starch Injection industry.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Hydroxyethyl Starch Injection market. The market attractiveness is moderate, driven by the increasing demand for volume expansion and blood loss replacement. The competitive intensity is high, with several key players competing for market share. The long-term outlook for the Hydroxyethyl Starch Injection market outlook is positive, with growing demand from emerging economies and advancements in medical technology.

The innovation landscape is evolving, with a focus on developing safer and more effective alternatives. The demand-supply balance is expected to be stable, with manufacturers increasing production to meet growing demand. Key risk factors include regulatory changes and raw material shortages. Overall, the Hydroxyethyl Starch Injection market is expected to experience steady growth, driven by increasing demand and advancements in medical technology.

12 items

1. Executive Summary

2. Hydroxyethyl Starch Injection Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Hydroxyethyl Starch Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Hydroxyethyl Starch Injection Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Hydroxyethyl Starch Injection Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Hydroxyethyl Starch Injection Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Hydroxyethyl Starch Injection Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Hydroxyethyl Starch Injection Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Hydroxyethyl Starch Injection Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Hydroxyethyl Starch Injection Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Hydroxyethyl Starch Injection Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Hydroxyethyl Starch Injection Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Hydroxyethyl Starch Injection Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Hydroxyethyl Starch Injection Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Hydroxyethyl Starch Injection Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Hydroxyethyl Starch Injection Market Competition by Key Manufacturers

9.1. Global Hydroxyethyl Starch Injection Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Hydroxyethyl Starch Injection: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. B.Braun

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Fresenius Kabi

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medisan

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Otsuka Pharmaceutical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Shandong Qidu Pharma Group

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Hangzhou Minsheng

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. PKU HealthCare Corp.,Ltd.

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shandong Hualu Pharmaceutical

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. CR Double-Crane

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shijiahzhuang No.4 Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. WEGO

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. CTTQ

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Kelun

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Sichuan Meida Kangjiale

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Huaren Pharmaceutical

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

10.16. Shandong Huaxin

10.16.1. Company Basic Information and Sales Area

10.16.2. Main Business/Business Overview

10.16.3. Product Portfolio

10.16.4. Financial

10.16.5. Recent Industry Insights

10.16.6. SWOT Analysis

10.17. Sichuan Guorui

10.17.1. Company Basic Information and Sales Area

10.17.2. Main Business/Business Overview

10.17.3. Product Portfolio

10.17.4. Financial

10.17.5. Recent Industry Insights

10.17.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Hydroxyethyl Starch Injection Market

Figure 4: Global Hydroxyethyl Starch Injection Market: Drivers

Figure 5: Global Hydroxyethyl Starch Injection Market: Challenges

Figure 6: Global Hydroxyethyl Starch Injection Market: Trends

Figure 7: Global Hydroxyethyl Starch Injection Market: Opportunity

Figure 8: Global Hydroxyethyl Starch Injection Market: Restraint

Figure 9: Global Hydroxyethyl Starch Injection Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Hydroxyethyl Starch Injection Market Value (USD Million) By Region

Figure 19: Global Hydroxyethyl Starch Injection Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Hydroxyethyl Starch Injection Market Value (USD Million) By Region

Figure 27: Global Hydroxyethyl Starch Injection Market Share (%) By: Regions (2032)

Figure 28: Global Hydroxyethyl Starch Injection Market Volume (K) By Region

Figure 29: Global Hydroxyethyl Starch Injection Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Hydroxyethyl Starch Injection Market Value (USD Million) By Region

Figure 37: Global Hydroxyethyl Starch Injection Market Share (%) By: Regions (2032)

Figure 38: Global Hydroxyethyl Starch Injection Market Volume (K) By Region

Figure 39: Global Hydroxyethyl Starch Injection Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

129 items

Table 1: Market Segmentation Analysis

Table 2: Global Hydroxyethyl Starch Injection Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Hydroxyethyl Starch Injection Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Hydroxyethyl Starch Injection Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Hydroxyethyl Starch Injection Market Value (USD Million) By Region

Table 14: Global Hydroxyethyl Starch Injection Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Hydroxyethyl Starch Injection Market Volume (K) By Region

Table 31: Global Hydroxyethyl Starch Injection Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Hydroxyethyl Starch Injection Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Hydroxyethyl Starch Injection Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Hydroxyethyl Starch Injection Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: B.Braun Basic Information And Sales Area

Table 52: B.Braun. Products Portfolio

Table 53: Fresenius Kabi Basic Information And Sales Area

Table 54: Fresenius Kabi. Products Portfolio

Table 55: Medisan Basic Information And Sales Area

Table 56: Medisan. Products Portfolio

Table 57: Otsuka Pharmaceutical Basic Information And Sales Area

Table 58: Otsuka Pharmaceutical. Products Portfolio

Table 59: Shandong Qidu Pharma Group Basic Information And Sales Area

Table 60: Shandong Qidu Pharma Group. Products Portfolio

Table 61: Hangzhou Minsheng Basic Information And Sales Area

Table 62: Hangzhou Minsheng. Products Portfolio

Table 63: PKU HealthCare Corp.,Ltd. Basic Information And Sales Area

Table 64: PKU HealthCare Corp.,Ltd.. Products Portfolio

Table 65: Shandong Hualu Pharmaceutical Basic Information And Sales Area

Table 66: Shandong Hualu Pharmaceutical. Products Portfolio

Table 67: CR Double-Crane Basic Information And Sales Area

Table 68: CR Double-Crane. Products Portfolio

Table 69: Shijiahzhuang No.4 Pharmaceutical Basic Information And Sales Area

Table 70: Shijiahzhuang No.4 Pharmaceutical. Products Portfolio

Table 71: WEGO Basic Information And Sales Area

Table 72: WEGO. Products Portfolio

Table 73: CTTQ Basic Information And Sales Area

Table 74: CTTQ. Products Portfolio

Table 75: Kelun Basic Information And Sales Area

Table 76: Kelun. Products Portfolio

Table 77: Sichuan Meida Kangjiale Basic Information And Sales Area

Table 78: Sichuan Meida Kangjiale. Products Portfolio

Table 79: Huaren Pharmaceutical Basic Information And Sales Area

Table 80: Huaren Pharmaceutical. Products Portfolio

Table 81: Shandong Huaxin Basic Information And Sales Area

Table 82: Shandong Huaxin. Products Portfolio

Table 83: Sichuan Guorui Basic Information And Sales Area

Table 84: Sichuan Guorui. Products Portfolio

Table 85: Global Market Value (USD Million) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Value (USD Million) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Market Volume (K) (2025-2032) By Application

Table 90: Global Market Share (%) By Application (2032)

Table 91: Global Market Volume (K) (2025-2032) By Types

Table 92: Global Market Share (%) By Types (2032)

Table 93: Global Hydroxyethyl Starch Injection Market Value (USD Million) By Region

Table 94: Global Hydroxyethyl Starch Injection Market Share (%) By Region (2025-2032)

Table 95: North America Market Value (USD Million) (2025-2032) By Country

Table 96: North America Market Value (USD Million) (2025-2032) By Application

Table 97: North America Market Value (USD Million) (2025-2032) By Types

Table 98: Europe Market Value (USD Million) (2025-2032) By Country

Table 99: Europe Market Value (USD Million) (2025-2032) By Application

Table 100: Europe Market Value (USD Million) (2025-2032) By Types

Table 101: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 102: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 103: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 104: South America Market Value (USD Million) (2025-2032) By Country

Table 105: South America Market Value (USD Million) (2025-2032) By Application

Table 106: South America Market Value (USD Million) (2025-2032) By Types

Table 107: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 108: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 109: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 110: Global Hydroxyethyl Starch Injection Market Volume (K) By Region

Table 111: Global Hydroxyethyl Starch Injection Market Share (%) By Region (2025-2032)

Table 112: North America Market Volume (K) (2025-2032) By Country

Table 113: North America Market Volume (K) (2025-2032) By Application

Table 114: North America Market Volume (K) (2025-2032) By Types

Table 115: Europe Market Volume (K) (2025-2032) By Country

Table 116: Europe Market Volume (K) (2025-2032) By Application

Table 117: Europe Market Volume (K) (2025-2032) By Types

Table 118: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 119: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 120: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 121: South America Market Volume (K) (2025-2032) By Country

Table 122: South America Market Volume (K) (2025-2032) By Application

Table 123: South America Market Volume (K) (2025-2032) By Types

Table 124: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 125: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 126: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 127: Research Programs/Design For This Report

Table 128: Key Data Information From Secondary Sources

Table 129: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Hydroxyethyl Starch Injection Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	450.00 million
Revenue forecast in 2033	728.13 million
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	B.Braun; Fresenius Kabi; Medisan; Otsuka Pharmaceutical; Shandong Qidu Pharma Group; Hangzhou Minsheng; PKU HealthCare Corp.,Ltd.; Shandong Hualu Pharmaceutical; CR Double-Crane; Shijiahzhuang No.4 Pharmaceutical; WEGO; CTTQ; Kelun; Sichuan Meida Kangjiale; Huaren Pharmaceutical; Shandong Huaxin; Sichuan Guorui
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The increasing use of Hydroxyethyl Starch Injection in critical care settings, such as intensive care units, is driving market growth due to its effectiveness in treating hypovolemia and shock.

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Hydroxyethyl Starch Injection Segmentation Breakdown9 items

Application

Hospitals

Drug Stores

Others

Types

Hydroxyethyl Starch 130/0.4 and Sodium Chloride Injection

Hydroxyethyl Starch 200/0.5 and Sodium Chloride Injection

Hydroxyethyl Starch 40 Sodium Chloride Injection

Others

Regional Insights

Loading chart…

Competitive Landscape

B.Braun: regional expansion

Fresenius Kabi: innovation pipeline

Medisan: local manufacturing

Otsuka Pharmaceutical: premium pricing

Shandong Qidu Pharma Group: OEM tie-ups

Hangzhou Minsheng: vertical integration

Key Hydroxyethyl Starch Injection Companies17 items

B.Braun

Fresenius Kabi

Medisan

Otsuka Pharmaceutical

Shandong Qidu Pharma Group

Hangzhou Minsheng

PKU HealthCare Corp.,Ltd.

Shandong Hualu Pharmaceutical

CR Double-Crane

Shijiahzhuang No.4 Pharmaceutical

WEGO

CTTQ

Kelun

Sichuan Meida Kangjiale

Huaren Pharmaceutical

Shandong Huaxin

Sichuan Guorui

Market Ecosystem

Raw material suppliers — provide starch and other components

OEMs / manufacturers — produce Hydroxyethyl Starch Injection products

Distributors / channel partners — deliver products to end users

End users / buyers — utilize Hydroxyethyl Starch Injection in medical settings

Regulators/standards bodies — oversee safety and efficacy standards

Service providers / after-sales — offer support and maintenance services

Data/analytics providers — supply market insights and research data

Recent Industry Insights

Analyst Overview

Table of Contents